Nurse Practitioner, Family · Tampa, FL
NPI
1053808790
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
13330 Usf Laurel Dr
Tampa, FL, 33612
Phone (813) 974-2201
Groups this clinician bills Medicare through
Medicare paid, 2024
$236K
41,877 services
Medicare patients, 2024
144
Average age 66
Drug cost, 2024
$1.3M
2,126 prescriptions
Company payments, 2025
$22K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marie E Labadie-Degennaro was code J0585 (injection, onabotulinumtoxina, 1 unit), 41,380 times for 69 patients. In total Marie E Labadie-Degennaro billed 41,877 services in 17 codes, and Medicare paid $236K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-06.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 41,380 | 69 | $4.82 | $199K |
| 64615 Musculoskeletal | Office | 206 | 70 | $103.12 | $21K |
| 99213 Office E&M - Established | Office | 69 | 56 | $52.91 | $3,651 |
| 99214 Office E&M - Established | Office | 55 | 46 | $73.49 | $4,042 |
| 20553 Musculoskeletal | Office | 47 | 12 | $32.23 | $1,515 |
| 64450 Musculoskeletal | Office | 36 | 15 | $36.42 | $1,311 |
| 64405 Musculoskeletal | Office | 36 | 15 | $63.75 | $2,295 |
By year: 2022 $111K for 17,418 services; 2023 $144K for 23,958 services; 2024 $236K for 41,877 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marie E Labadie-Degennaro prescribed most often to Medicare patients was Nurtec Odt (Rimegepant Sulfate), with 250 prescriptions and refills. In total Marie E Labadie-Degennaro wrote 2,126 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Nurtec Odt Rimegepant Sulfate | 250 | 269 | 45 | $391K |
| Ubrelvy Ubrogepant | 249 | 268 | 46 | $413K |
| Emgality Pen Galcanezumab-Gnlm | 163 | 182 | 26 | $129K |
| Qulipta Atogepant | 103 | 121 | 23 | $128K |
| Gabapentin Generic | 85 | 122 | 24 | $1,071 |
| Baclofen Generic | 83 | 112 | 19 | $935 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 70 | 76 | 18 | $514 |
| Aimovig Autoinjector Erenumab-Aooe | 70 | 103 | 17 | $76K |
| Amitriptyline Hcl Generic | 68 | 117 | 15 | $1,068 |
| Tizanidine Hcl Generic | 66 | 92 | 18 | $963 |
| Memantine Hcl Generic | 54 | 113 | 18 | $1,074 |
| Ondansetron Odt Ondansetron | 54 | 54 | 13 | $685 |
| Topiramate Generic | 43 | 94 | 15 | $382 |
| Naratriptan Hcl Generic | 40 | 44 | 19 | $769 |
| Prochlorperazine Maleate Generic | 40 | 40 | Under 11 | $434 |
Brand drugs: 938 claims; generic drugs: 1,188 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marie E Labadie-Degennaro $22K ($22K in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $11K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 51 | $11K |
| Pfizer Inc. PFE | 40 | $5,697 |
| Impel Pharmaceuticals LLC | 18 | $3,131 |
| Lundbeck LLC | 8 | $1,603 |
| Teva Pharmaceuticals USA, Inc. TEVA | 15 | $442 |
| Axsome Therapeutics, Inc. AXSM | 12 | $352 |
| Scilex Pharmaceuticals Inc. | 2 | $47.6 |
| Tonix Medicines, Inc. | 2 | $38.93 |
| Hologic Sales and Service, LLC HOLX | 1 | $26.68 |
| Lilly USA, LLC LLY | 1 | $15.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.